HIGHLIGHTS
- who: Conformation Matters and collaborators from the Institute for Biomedical Sciences, George Washington University, Washington, DC, USA have published the article: Epitope-Specific Serological Assays for RSV:, in the Journal: Vaccines 2019, 7, 23 of /2019/
- what: The authors show that antibodies to adjacent antigenic sites can contribute to DCA and PCA readouts and that cross-competition from non-targeted sites is especially confounding when PCA is measured using a post-F substrate. The aim of an RSV vaccine is to prevent severe disease in those at greatest risk-infants under 6 months of age . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.